Invention Grant
- Patent Title: Triazolopyridine compounds useful as DGAT1 inhibitors
- Patent Title (中): 可用作DGAT1抑制剂的三唑并吡啶化合物
-
Application No.: US12936997Application Date: 2009-04-10
-
Publication No.: US08394823B2Publication Date: 2013-03-12
- Inventor: Chongqing Sun
- Applicant: Chongqing Sun
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Burton Rodney
- International Application: PCT/US2009/040163 WO 20090410
- International Announcement: WO2009/126861 WO 20091015
- Main IPC: A61K31/437
- IPC: A61K31/437 ; C07D471/04 ; A61P3/04 ; A61P3/10
Abstract:
Disclosed are triazolopyridine compounds of the following Formula (I); or stereoisomers or salts thereof. Also, disclosed are methods of using the compound in the treatment of obesity, dyslipidemia, diabetes and atherosclerosis, and to pharmaceutical compositions comprising at least one compound of Formula (I) or a stereoisomer or pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20110034506A1 TRIAZOLOPYRIDINE COMPOUNDS USEFUL AS DGAT1 INHIBITORS Public/Granted day:2011-02-10
Information query
IPC分类:
